U.S., March 3 -- ClinicalTrials.gov registry received information related to the study (NCT07443475) titled 'Electrochemotherapy for Recurrent Vulvar Cancer' on Feb. 18.
Brief Summary: This phase I/II interventional study evaluates the effectiveness and safety of electrochemotherapy (ECT) as neoadjuvant treatment for local recurrence of vulvar cancer. Electrochemotherapy combines intravenous administration of bleomycin with delivery of electric pulses to the tumor area, increasing drug uptake into cancer cells. The main goal is to assess tumor response and reduce the need for mutilating surgical procedures, thereby improving quality of life in women with recurrent vulvar cancer. Participants will be followed prospectively and treatment out...